EBiSC Postdoctoral Research Fellow

PhD, LLM, LLB, BSc


View my full research profile

Biography

Carol George is a Senior Research Fellow at the University of Edinburgh, currently taking a lead role in the EU project for the establishment of the European Bank for induced pluripotent Stem Cells (EBiSC), which is coordinated by Pfizer Ltd and Censo Biotechnologies (previously Roslin Cells Ltd), and funded by the EU's Innovative Medicines Initiative (IMI) and members of the European Federation of Pharmaceutical Industries and Associations (EFPIA).  In addition to facilitating the development of ethical and legal governance frameworks for EBiSC, Carol is developing teaching materials for an on-campus LLM course in 'Governance of Innovative Medicine' (and its ODL counterpart 'Governance of Medical Research and Innovation') offered in Semester 1, 2017-18. Carol is interested in design-led integrative approaches to governance of emerging technologies that are capable of addressing the public-private divide, international regulatory diversity, and ethical and social pluralism, to facilitate the production of public goods for health. Carol is a PhD graduate of the AHRC-SCRIPT Centre at the School of Law, University of Edinburgh, and prior to her doctorate (‘Openness and the Governance of Human Stem Cell Lines: a conceptual approach'), Carol completed an LLM in Public International Law (London School of Economics & Political Science), coordinated the WTO Practice Group of global law firm Baker McKenzie, and was Head of Policy at Cambridge-based PHG (public health genomics) Foundation. Carol also has degrees in Science (BSc Biology) and Laws (LLB) from the University of British Columbia, and practiced commercial law in British Columbia, Canada.

Websites

Dr Carol George's homepage at Edinburgh Law School

Biography

Carol George is a Senior Research Fellow at the University of Edinburgh, currently taking a lead role in the EU project for the establishment of the European Bank for induced pluripotent Stem Cells (EBiSC), which is coordinated by Pfizer Ltd and Censo Biotechnologies (previously Roslin Cells Ltd), and funded by the EU's Innovative Medicines Initiative (IMI) and members of the European Federation of Pharmaceutical Industries and Associations (EFPIA).  In addition to facilitating the development of ethical and legal governance frameworks for EBiSC, Carol is developing teaching materials for an on-campus LLM course in 'Governance of Innovative Medicine' (and its ODL counterpart 'Governance of Medical Research and Innovation') offered in Semester 1, 2017-18. Carol is interested in design-led integrative approaches to governance of emerging technologies that are capable of addressing the public-private divide, international regulatory diversity, and ethical and social pluralism, to facilitate the production of public goods for health. Carol is a PhD graduate of the AHRC-SCRIPT Centre at the School of Law, University of Edinburgh, and prior to her doctorate (‘Openness and the Governance of Human Stem Cell Lines: a conceptual approach'), Carol completed an LLM in Public International Law (London School of Economics & Political Science), coordinated the WTO Practice Group of global law firm Baker McKenzie, and was Head of Policy at Cambridge-based PHG (public health genomics) Foundation. Carol also has degrees in Science (BSc Biology) and Laws (LLB) from the University of British Columbia, and practiced commercial law in British Columbia, Canada.

Websites

Dr Carol George's homepage at Edinburgh Law School

Articles

Michael Morrison, Jessica Bell, Carol George, Shawn Harmon, Megan Munsie, Jane Kaye, 'The European general data protection regulation: Challenges and considerations for iPSC researchers and biobanks', (2017), Regenerative medicine, Vol 12, pp 693-703
Abstract: Increasingly, human induced pluripotent stem cells (iPSC) and their associated genetic and clinical information are being used in a wide range of applications, with large biobanks being established to support and increase their scientific use. The new European General Data Protection Regulations, which comes into effect in 2018, will have implications for biobanks that generate, store and allow research access toiPSC. This paper describes some of the challenges that iPSC biobanks face and suggests some points for the development of appropriate governance structures to address these new requirements. These suggestions also have implications for iPSC research in general.

Paul A. De Sousa, Rachel Steeg, Elisabeth Wachter, Kevin Bruce, Jason King, Marieke Hoeve, Shalinee Khadun, George Mcconnachie, Julie Holder, Andreas Kurtz, Stefanie Seltmann, Johannes Dewender, Sascha Reimann, Glyn Stacey, Orla O'shea, Charlotte Chapman, Lyn Healy, Heiko Zimmermann, Bryan Bolton, Trisha Rawat, Isobel Atkin, Anna Veiga, Bernd Kuebler, Blanca Miranda Serano, Tomo Saric, Jürgen Hescheler, Oliver Brüstle, Michael Peitz, Cornelia Thiele, Niels Geijsen, Bjørn Holst, Christian Clausen, Majlinda Lako, Lyle Armstrong, Shailesh K. Gupta, Alexander J. Kvist, Ryan Hicks, Anna Jonebring, Gabriella Brolén, Andreas Ebneth, Alfredo Cabrera-socorro, Patrik Foerch, Martine Geraerts, Tina C. Stummann, Shawn Harmon, Carol George, Ian Streeter, Laura Clarke, Helen Parkinson, Peter W. Harrison, Adam Faulconbridge, Luca Cherubin, Tony Burdett, Cesar Trigueros, Minal J Patel, Christa Lucas, Barry Hardy, Rok Predan, Joh Dokler, Maja Brajnik, Oliver Keminer, Ole Pless, Philip Gribbon, Carsten Claussen, Annette Ringwald, Beate Kreisel, Aidan Courtney, Timothy E. Allsopp, 'Rapid establishment of the European Bank for induced Pluripotent Stem Cells (EBiSC): The Hot Start experience', (2017), Stem cell research, Vol 20, pp 105-114
Abstract: AbstractA fast track “Hot Start” process was implemented to launch the European Bank for Induced Pluripotent Stem Cells (EBiSC) to provide early release of a range of established control and disease linked human induced pluripotent stem cell (hiPSC) lines. Established practice amongst consortium members was surveyed to arrive at harmonised and publically accessible Standard Operations Procedures (SOPs) for tissue procurement, bio-sample tracking, iPSC expansion, cryopreservation, qualification and distribution to the research community. These were implemented to create a quality managed foundational collection of lines and associated data made available for distribution. Here we report on the successful outcome of this experience and work flow for banking and facilitating access to an otherwise disparate European resource, with lessons to benefit the international research community.eTOCThe report focuses on the EBiSC experience of rapidly establishing an operational capacity to procure, bank and distribute a foundational collection of established hiPSC lines. It validates the feasibility and defines the challenges of harnessing and integrating the capability and productivity of centres across Europe using commonly available resources currently in the field.